INTENSITY THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
INTENSITY THERAPEUTICS, INC. (INTS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $18.30 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2023-11-13
- INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2023-09-30 was $13.20K, a 83.33% increase year-over-year.
- INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2022-09-30 was $7.20K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 9 month |
|---|---|---|---|
| 2023-09-30 | $13.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-13 | $18.30K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.10K 10-Q/A · filed 2023-08-14 | ||
| 2022-09-30 | $7.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-13 | $47.70K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $40.50K 10-Q/A · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |